| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EHMT2 and SLC44A4 antisense RNA 1 | 0.780 | 0.462 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2013 | 2017 | ||||||||
|
Fc fragment of IgG receptor IIIa | 0.432 | 0.962 | 3.7E-06 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2013 | 2018 | ||||||||
|
fibroblast growth factor 13 | 0.514 | 0.808 | 0.89 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
FERM domain containing 4A | 0.650 | 0.538 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
follistatin like 3 | 0.695 | 0.423 | 0.69 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
grancalcin | 0.590 | 0.731 | 1.4E-04 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2019 | ||||||||
|
histone deacetylase 9 | 0.439 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1982 | 2007 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.500 | None | 0.960 | 25 | 2 | 1993 | 2018 | ||||||||
|
major histocompatibility complex, class II, DO alpha | 0.509 | 0.808 | 3.0E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
major histocompatibility complex, class II, DO beta | 0.705 | 0.500 | 1.9E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
major histocompatibility complex, class II, DP alpha 1 | 0.552 | 0.846 | 2.5E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 1992 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1992 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1992 | 2017 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
heat shock protein family A (Hsp70) member 4 | 0.394 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
heat shock protein family D (Hsp60) member 1 | 0.432 | 0.808 | 0.99 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1998 | 2017 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |